当前位置:首页 - 行情中心 - 恩威医药(301331) - 财务分析

恩威医药

(301331)

  

流通市值:10.43亿  总市值:32.42亿
流通股本:3310.17万   总股本:1.03亿

恩威医药(301331)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润0.16亿元,每股收益0.16元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益107650.50万元,未分配利润35464.09万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产149627.01万元,负债41976.52万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入196,499,491.35812,127,431.13560,341,100.4388,149,545.27
营业总成本183,733,734.69763,172,474.47534,869,746.2365,609,056.27
营业利润18,195,945.0849,686,515.9928,533,339.8323,349,097.61
利润总额17,986,639.7446,683,834.3225,522,582.0522,937,854.76
净利润16,305,126.8937,497,544.3522,021,962.5817,934,442.73
其他综合收益----
综合收益总额16,305,126.8937,497,544.3522,021,962.5817,934,442.73
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计942,025,659.66952,037,157.23864,538,310.27916,330,278.24
非流动资产合计554,244,464.41552,491,760.82558,356,241.46554,995,644.5
资产总计1,496,270,124.071,504,528,918.051,422,894,551.731,471,325,922.74
流动负债合计212,532,003.52238,422,148.41178,024,258.43214,825,398.51
非流动负债合计207,233,151.98208,435,686.15222,906,155.01242,939,946.91
负债合计419,765,155.5446,857,834.56400,930,413.44457,765,345.42
归属于母公司股东权益合计1,076,504,968.571,057,671,083.491,021,964,138.291,013,560,577.32
股东权益合计1,076,504,968.571,057,671,083.491,021,964,138.291,013,560,577.32
负债和股东权益合计1,496,270,124.071,504,528,918.051,422,894,551.731,471,325,922.74
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计199,901,802.99749,688,281.63567,084,978.47423,270,003.91
经营活动现金流出小计175,223,677.5670,768,561.8495,620,500.73332,999,030.85
经营活动产生的现金流量净额24,678,125.4978,919,719.8371,464,477.7490,270,973.06
投资活动现金流入小计422,479,327.18957,717,557.13640,603,505.93442,449,344.84
投资活动现金流出小计442,453,732.731,068,334,929.94654,088,085.94411,663,935.46
投资活动产生的现金流量净额-19,974,405.55-110,617,372.81-13,484,580.0130,785,409.38
筹资活动现金流入小计-260,163,611.13241,800,000241,800,000
筹资活动现金流出小计828,750175,059,041.11170,167,751.6145,260,362.71
筹资活动产生的现金流量净额-828,75085,104,570.0271,632,248.496,539,637.29
汇率变动对现金及现金等价物的影响-8.6990.3-64.3240.39
现金及现金等价物净增加额3,874,961.2553,407,007.34129,612,081.81217,596,060.12
期末现金及现金等价物余额293,098,750.8289,223,789.55365,428,864.02453,412,842.33
TOP↑